Multiple system atrophy (MSA) is a neurodegenerative disorder with limited treatment options. However, recent research has yielded promising discoveries into new therapeutic approaches. Current efforts centers on targeting the underlying pathophysiology of MSA. One approach under investigation involves pharmacological interventions to modulate the